DrugRisk has learned of a new development in the NuvaRing blood clot litigation that could mean a settlement for victims in the near future. A judge overseeing lawsuits recently delayed the start of the first trial and asked lawyers to give an updated count of cases.
Lawsuits have swelled in the past year to over 1,500 after thousands of women discovered they developed dangerous blood clots or conditions like deep vein thrombosis (DVT), pulmonary embolism or stroke after using the device.
NuvaRing is a small, flexible plastic ring that is inserted once per month to give up to a month of pregnancy prevention. It has been on the market since 2000 and has been used by millions of women as an alternative to daily birth control pills.
Unfortunately, experts have found the devices may be linked to blood clots. Last year, both the New England Journal of Medicine and British Medical Journal published studies showing vaginal ring contraceptives could cause 200-600% higher risks of blood clots.
Although the maker of NuvaRing, Merck, advertised the device as using lower hormones, experts believe the constant and direct absorption of these chemicals into the bloodstream could be a safety concern.
FDA records show thousands of patients have reported blood clot injuries after using NuvaRing. As more and women filed a NuvaRing lawsuit, cases were consolidated to a special federal multidistrict litigation court in Missouri.
The latest court records show the number of cases filed has grown to 1,563 as of November 18.
Now, DrugRisk has learned that U.S. District Judge Rodney Sippel, who is overseeing the litigation, has postponed the start of the first trial from January to April 7, 2014. He has also asked attorneys handling these cases to provide a list of all anticipated claims.
Experts believe the delay of trials and census requested by Judge Sippel could be a sign that the parties are entering new negotiations to settle all NuvaRing blood clot lawsuits. If so, it is important for anyone affected who has not yet filed a claim to do so.
If you or a loved one suffered a blood clot, stroke, DVT or pulmonary embolism after using NuvaRing, contact us today to speak with a lawyer about your legal rights. DrugRisk only recommends lawyers and law firms who have already handled NuvaRing lawsuits.
We are available 24 hours a day to provide more information on the research, side effects and litigation news related to NuvaRing. Contact us today.